- Home
- SUPN vs ABM Comparison
SUPN vs ABM Comparison
Compare SUPN & ABM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SUPN | ABM |
|---|---|---|
| Founded | 2005 | 1909 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2010 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SUPN | ABM |
|---|---|---|
| Price | $54.18 | $44.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $61.60 | $51.50 |
| AVG Volume (30 Days) | ★ 781.0K | 415.8K |
| Earning Date | 05-21-2026 | 03-18-2026 |
| Dividend Yield | N/A | ★ 2.59% |
| EPS Growth | ★ 6500.00 | 102.34 |
| EPS | N/A | ★ 2.59 |
| Revenue | $392,755,000.00 | ★ $8,745,900,000.00 |
| Revenue This Year | $8.18 | $5.71 |
| Revenue Next Year | $22.15 | $1.99 |
| P/E Ratio | ★ N/A | $17.31 |
| Revenue Growth | N/A | ★ 4.62 |
| 52 Week Low | $29.16 | $40.00 |
| 52 Week High | $59.68 | $54.90 |
Technical Indicators
Market Signals| Indicator | SUPN | ABM |
|---|---|---|
| Relative Strength Index (RSI) | 60.66 | 46.46 |
| Support Level | $47.95 | $44.37 |
| Resistance Level | $57.65 | $46.93 |
| Average True Range (ATR) | 2.13 | 1.29 |
| MACD | 0.49 | -0.20 |
| Stochastic Oscillator | 46.18 | 35.55 |
Price Performance
Historical ComparisonAbout SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.